Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Intravenous (IV) Therapy and Vein Access Market to Reach $33.9 Billion by 2025: Rise in Surgical Method Volumes & Growing Number of Road Accidents - Research and Markets

Research and Markets
Posted on: 23 Aug 17

The "Global Intravenous (IV) Therapy and Vein Access Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

The Global Intravenous (IV) Therapy and Vein Access Market is poised to grow at a CAGR of around 7.3% over the next decade to reach approximately $33.91 billion by 2025. Some of the prominent trends that the market is witnessing include rise in surgical method volumes and growing number of road accidents.

Based on medical application the market is categorized into medication administration, nutrition and buffer solution, volume expanders and blood based products.

By product, market is segregated by intravenous catheter, infusion pumps, implantable port, hypodermic needles and other products. Intravenous Catheter segment is further sub segmented into central intravenous catheter, peripherally inserted central catheter and peripheral intravenous catheter. Implantable port divided into double lumen implantable port and single lumen implantable port.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Companies Mentioned

  • Terumo Medical Corporation
  • BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
  • Baxter International Inc.
  • iRadimed Corporation
  • Becton, Dickinson and Company
  • Grifols, S.A.
  • Teleflex Medical Inc.
  • CVS Health Corporation
  • Smith & Nephew plc
  • AngioDynamics, Inc.
  • Medtronic Inc.
  • B. Braun Melsungen AG
  • Vifor Pharma Group
  • Insulet Corporation
  • BioScrip, Inc.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Intravenous (IV) Therapy and Vein Access Market, By Medical Application

5 Intravenous (IV) Therapy and Vein Access Market, By End User

6 Intravenous (IV) Therapy and Vein Access Market, By Product

7 Intravenous (IV) Therapy and Vein Access Market, By Geography

For more information about this report visit

View source version on

Business Wire

Last updated on: 23/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.